| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |